Amgen Announces Webcast Of Third-Quarter 2002 Financial Results Read more about Amgen Announces Webcast Of Third-Quarter 2002 Financial Results
Amgen's Third Quarter 2002 Adjusted Earnings Per Share Increase 13% To 34 Cents Read more about Amgen's Third Quarter 2002 Adjusted Earnings Per Share Increase 13% To 34 Cents
First-In-Class Oral Calcimimetic Shown To Reduce Parathyroid Hormone Levels In Chronic Kidney Disease Read more about First-In-Class Oral Calcimimetic Shown To Reduce Parathyroid Hormone Levels In Chronic Kidney Disease
First-In-Class Oral Calcimimetic Shown To Reduce Parathyroid Hormone Levels In Chronic Kidney Disease Read more about First-In-Class Oral Calcimimetic Shown To Reduce Parathyroid Hormone Levels In Chronic Kidney Disease
Amgen Business Review Meeting Resheduled To February 25, 2003 Read more about Amgen Business Review Meeting Resheduled To February 25, 2003
Serono And Amgen Sign License Agreement For Multiple Sclerosis Product Read more about Serono And Amgen Sign License Agreement For Multiple Sclerosis Product
Amgen Files Suit Seeking Relief From Reimbursement Ruling Read more about Amgen Files Suit Seeking Relief From Reimbursement Ruling
Enbrel Offered To Additional 40,000 Rheumatoid Arthritis, Juvenile Rheumatoid Arthritis And Psoriatic Arthritis Patients Read more about Enbrel Offered To Additional 40,000 Rheumatoid Arthritis, Juvenile Rheumatoid Arthritis And Psoriatic Arthritis Patients
Amgen Announces Webcast Of Conference Call To Provide Financial Guidance For 2003 Read more about Amgen Announces Webcast Of Conference Call To Provide Financial Guidance For 2003
